Loading…
Histone Deacetylase Inhibitors (HDI) Cause DNA Damage in Leukemia Cells: A Mechanism for Leukemia-Specific HDI-Dependent Apoptosis?
Histone deacetylase inhibitors (HDI) increase gene expression through induction of histone acetylation. However, it remains unclear whether increases in specific gene expression events determine the apoptotic response following HDI administration. Herein, we show that a variety of HDI trigger in hem...
Saved in:
Published in: | Molecular cancer research 2006-08, Vol.4 (8), p.563-573 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Histone deacetylase inhibitors (HDI) increase gene expression through induction of histone acetylation. However, it remains
unclear whether increases in specific gene expression events determine the apoptotic response following HDI administration.
Herein, we show that a variety of HDI trigger in hematopoietic cells not only widespread histone acetylation and DNA damage
responses but also actual DNA damage, which is significantly increased in leukemic cells compared with normal cells. Thus,
increase in H2AX and ataxia telangiectasia mutated (ATM) phosphorylation, early markers of DNA damage, occurs rapidly following
HDI administration. Activation of the DNA damage and repair response following HDI treatment is further emphasized by localizing
DNA repair proteins to regions of DNA damage. These events are followed by subsequent apoptosis of neoplastic cells but not
normal cells. Our data indicate that induction of apoptosis by HDI may result predominantly through accumulation of excessive
DNA damage in leukemia cells, leading to activation of apoptosis. (Mol Cancer Res 2006;4(8):563–73) |
---|---|
ISSN: | 1541-7786 1557-3125 |
DOI: | 10.1158/1541-7786.MCR-06-0111 |